Learn more

ULTIMORPHIX TECHNOLOGIES B V

Overview
  • Total Patents
    18
About

ULTIMORPHIX TECHNOLOGIES B V has a total of 18 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are IMMUGEN PHARMACEUTICALS INC, ESPERION THERAPEUTICS INC and HOLMEIDE ANNE KRISTIN.

Patent filings in countries

World map showing ULTIMORPHIX TECHNOLOGIES B Vs patent filings in countries
# Country Total Patents
#1 WIPO (World Intellectual Property Organization) 6
#2 EPO (European Patent Office) 4
#3 Canada 3
#4 United States 3
#5 China 2

Patent filings per year

Chart showing ULTIMORPHIX TECHNOLOGIES B Vs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Organic fine chemistry

Top inventors

# Name Total Patents
#1 Dova Evanthia 15
#2 Mazurek Jaroslaw Marek 6
#3 Anker Johnny 5
#4 Kulkarni Samir 4
#5 Hoffmann Marcel 2
#6 Ramos Rita 2
#7 Evanthia Dova 2
#8 Marek Mazurek Jaroslaw 1
#9 Johnny Anker 1
#10 Dova Evantha 1

Latest patents

Publication Filing date Title
WO2010142761A1 The succinate of tenofovir disoproxil
CA2744211A1 Wet granulation of tenofovir, emtricitabine and efavirenz
CN101918418A Solid forms of tenofovir disoproxil
WO2009064174A1 Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
WO2009011567A1 Crystalline forms of efavirenz
CN101778855A Tenofovir disoproxil hemi-fumaric acid co-crystal
WO2008140302A1 Polymorphic forms of tenofovir disoproxil fumarate
WO2008108630A1 Polymorphic forms of efavirenz